The global drug delivery in cancer market size was valued at USD 120.05 billion in 2025 and is expected to reach USD 230.56 billion by 2033, at a CAGR of 8.50% during the forecast period
The market growth is largely fueled by technological progress in targeted drug delivery systems, including protein-drug conjugates, PEGylated proteins, liposomes, and polymer nanoparticles, leading to improved treatment precision and efficacy in cancer car
Furthermore, increasing demand for safe, efficient, and patient-friendly delivery mechanisms is driving the adoption of advanced drug delivery platforms in clinics and hospitals, accelerating the uptake of cancer therapies and significantly boosting industry growth
6 vistas